verapamil has been researched along with Coronary Thrombosis in 8 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
Coronary Thrombosis: Coagulation of blood in any of the CORONARY VESSELS. The presence of a blood clot (THROMBUS) often leads to MYOCARDIAL INFARCTION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We report on a 46-year-old male with unstable angina pectoris due to a total proximal occlusion of the left circumflex artery." | 1.30 | [Anti-ischemic effect of verapamil within the scope of interventional recanalization]. ( Baumgart, D; Caspari, G; Eggebrecht, H; Erbel, R; Haude, M; Oldenburg, O; Schaar, J, 1999) |
| " Verapamil alone had no protective effect on reperfused myocardium, whereas dibunol, and particularly its combination with verapamil, essentially limited the size of necrosis, reduced plasma CPK activity and animal mortality rate and maintained ultrastructural integrity of cardiomyocytes, which was accompanied by a decrease of plasma lipid peroxidation products and a stabilization of cardiomyocyte sarcolemma." | 1.27 | [Prevention of myocardial damage during reperfusion of the coronary artery in dogs using dibunol combined with verapamil]. ( Golikov, AP; Konorev, EA; Pichugin, VV; Polumiskov, VIu; Sharov, VG, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (37.50) | 18.7374 |
| 1990's | 5 (62.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kirchengast, M | 1 |
| Rübsamen, K | 1 |
| Lehmann, HD | 1 |
| Beuckelmann, DJ | 1 |
| Górski, J | 1 |
| Nowak, J | 1 |
| Flasiński, J | 1 |
| Słonecka, A | 1 |
| Birkholz, A | 1 |
| Kurek, P | 1 |
| Dmochowska, W | 1 |
| Korzeniowski, A | 1 |
| Danenberg, HD | 1 |
| Hasin, Y | 1 |
| Gilon, D | 1 |
| Oldenburg, O | 1 |
| Baumgart, D | 1 |
| Schaar, J | 1 |
| Eggebrecht, H | 1 |
| Caspari, G | 1 |
| Haude, M | 1 |
| Erbel, R | 1 |
| Buonanno, C | 1 |
| Kanmatsuse, K | 1 |
| Kajiwara, N | 1 |
| Onikura, S | 1 |
| Nagao, K | 1 |
| Satoh, Y | 1 |
| Yumi, K | 1 |
| Golikov, AP | 1 |
| Pichugin, VV | 1 |
| Konorev, EA | 1 |
| Polumiskov, VIu | 1 |
| Sharov, VG | 1 |
8 other studies available for verapamil and Coronary Thrombosis
| Article | Year |
|---|---|
Inhibition by the combined Ca2+ and 5-HT2 receptor antagonist nexopamil (LU 49938) of intracoronary thrombus formation in a canine model of arterial stenosis and intimal damage.
Topics: Animals; Calcium; Coronary Circulation; Coronary Thrombosis; Dogs; Female; Gallopamil; Hemodynamics; | 1993 |
[Calcium antagonist protects the heart from ischemia and thrombosis].
Topics: Angina Pectoris; Calcium Channel Blockers; Coronary Thrombosis; Dose-Response Relationship, Drug; Hu | 1996 |
Verapamil influences the effect of nonionic contrast agent on platelet membrane structure and aggregation.
Topics: Calcium Channel Blockers; Contrast Media; Coronary Angiography; Coronary Thrombosis; Electron Spin R | 1995 |
A 42-year-old man with recurrent myocardial infarction and normal appearing coronary arteries.
Topics: Adult; Aspirin; Coronary Thrombosis; Humans; Male; Microvascular Angina; Myocardial Infarction; Plat | 1999 |
[Anti-ischemic effect of verapamil within the scope of interventional recanalization].
Topics: Angina, Unstable; Angioplasty, Balloon, Coronary; Blood Flow Velocity; Calcium Channel Blockers; Cor | 1999 |
[Acute coronary occlusion during transluminal angioplasty: role of coronary thrombosis].
Topics: Aged; Angiography; Angioplasty, Balloon; Coronary Angiography; Coronary Disease; Coronary Thrombosis | 1988 |
Experimental and clinical investigations for the time interval from onset of symptoms to the coronary reperfusion.
Topics: Adult; Aged; Animals; Coronary Thrombosis; Creatine Kinase; Dogs; Female; Humans; Male; Middle Aged; | 1988 |
[Prevention of myocardial damage during reperfusion of the coronary artery in dogs using dibunol combined with verapamil].
Topics: Animals; Antioxidants; Butylated Hydroxytoluene; Coronary Circulation; Coronary Disease; Coronary Th | 1987 |